Pourdjabbar Ali, Ang Lawrence, Reeves Ryan R, Patel Mitul P, Mahmud Ehtisham
Division of Cardiovascular Medicine, University of California, San Diego Sulpizio Cardiovascular Center, La Jolla, CA, USA.
Rambam Maimonides Med J. 2017 Jul 31;8(3):e0030. doi: 10.5041/RMMJ.10291.
Robotic technology has been used in cardiovascular medicine for over a decade, and over that period its use has been expanded to interventional cardiology and percutaneous coronary and peripheral vascular interventions. The safety and feasibility of robotically assisted interventions has been demonstrated in multiple studies ranging from simple to complex coronary lesions, and in the treatment of iliofemoral and infrapopliteal disease. These studies have shown a reduction in operator exposure to harmful ionizing radiation, and the use of robotics has the intuitive benefit of alleviating the occupational hazard of operator orthopedic injuries. In addition to the interventional operator benefits, robotically assisted intervention has the potential to also be beneficial for patients by allowing more accurate lesion length measurement, stent placement, and patient radiation exposure; however, more investigation is required to elucidate these benefits fully.
机器人技术应用于心血管医学领域已有十多年,在此期间,其应用范围已扩展到介入心脏病学以及经皮冠状动脉和外周血管介入治疗。从简单到复杂的冠状动脉病变,以及在髂股动脉和腘动脉以下疾病的治疗中,多项研究已证明了机器人辅助介入治疗的安全性和可行性。这些研究表明,操作人员接触有害电离辐射的情况有所减少,而且使用机器人技术具有直观的好处,即减轻了操作人员遭受骨科损伤的职业危害。除了对介入操作人员有益外,机器人辅助介入治疗还可能对患者有益,因为它可以实现更精确的病变长度测量、支架置入以及减少患者的辐射暴露;然而,需要进行更多研究来充分阐明这些益处。